Search Orphan Drug Designations and Approvals
-
Generic Name: | macitentan |
---|---|
Date Designated: | 06/15/2017 |
Orphan Designation: | Treatment of chronic thromboembolic pulmonary hypertension (CTEPH) |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 10/22/2024 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Actelion Pharmaceuticals Ltd. (a Janssen Pharmaceutical Company of Johnson and Johnson) Gewerbestrasse 16 Allschwil CH-4123 Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-